Glycovaxin logo
Healthcare & Life Sciences

Glycovaxin

Glycovaxin is a Healthcare & Life Sciences startup based in Germany, most recent round Seed.

Acquiredseed
seed
Stage
2018
Founded

About Glycovaxin

Glycovaxin is a company founded in 2018 headquartered in Germany. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences.

Glycovaxin is a biotechnology company developing a new generation of vaccines against bacterial infections. They utilize synthetic carbohydrate chemistry to create innovative vaccine candidates.

Explore Glycovaxin's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Germany